Category: Psychedelic Bulletin - Page 10 - Psychedelic Alpha

Read more about the article Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule; Australia’s National Science Agency Working on Psychedelics; Death Spiral Financings

Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule; Australia’s National Science Agency Working on Psychedelics; Death Spiral Financings

Post published:May 22, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety Results; Mail-Order Ketamine May Come Under Scrutiny; Our Notes from PSYCH Symposium

Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety Results; Mail-Order Ketamine May Come Under Scrutiny; Our Notes from PSYCH Symposium

Post published:May 16, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin #101 – Psychedelic R&D in the UK; COMPASS Study Points to Psilocybin for Anorexia

Psychedelic Bulletin #101 – Psychedelic R&D in the UK; COMPASS Study Points to Psilocybin for Anorexia

Post published:May 6, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine Therapy; Psychedelics Research Review

Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine Therapy; Psychedelics Research Review

Post published:April 25, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse Stock-Split; Are Magic Mushrooms Giving Investors a Bad Trip?

Psychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse Stock-Split; Are Magic Mushrooms Giving Investors a Bad Trip?

Post published:April 15, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Homecoming Raises $4m Seed; Angermayer Increases atai Stake by 1m Shares; 6 Projects Readers are Working On

Psychedelic Bulletin: Homecoming Raises $4m Seed; Angermayer Increases atai Stake by 1m Shares; 6 Projects Readers are Working On

Post published:April 8, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Bizarre News from Across the Psychedelics Space (April 1, 2022)

Psychedelic Bulletin: Bizarre News from Across the Psychedelics Space (April 1, 2022)

Post published:April 1, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: COMPASS Partners with NHS Trust to Launch Centre; Disturbing Footage Emerges from MAPS Trial

Psychedelic Bulletin: COMPASS Partners with NHS Trust to Launch Centre; Disturbing Footage Emerges from MAPS Trial

Post published:March 25, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

Post published:March 18, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Tensions Rise Among Oregon’s Psilocybin Advisory Board; Colleges Team up to Develop Psychedelic Curriculum

Psychedelic Bulletin: Tensions Rise Among Oregon’s Psilocybin Advisory Board; Colleges Team up to Develop Psychedelic Curriculum

Post published:March 11, 2022
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.